Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

The disease hobbles families and economies.

Melanoma survivor T.J. Sharpe discusses the importance of clinical trials to help raise awareness among the community.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.

Today, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.

Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.

Novartis-Harvard team identifies a new type of cell that is key to the disease.